Viewing SEC Facts Units
Company Name:
Summit Therapeutics Inc.
CIK:
1599298
Start Filing Date:
2019-05-01
End Filing Date:
2019-07-31
ACCN:
0001599298-19-000017
Value:
$ 160,495,000
Value Error:
$ None
Created By:
Date Filed:
2019-10-11
FY:
2020
Fiscal Period:
Q2
Frame:
CY2019Q2
Type:
ifrs-full
Form:
6-K
Units:
shares